MEDIROM Healthcare Technologies Inc.
MEDIROM Healthcare Technologies Inc. (MRM) Revenue
Annual & quarterly revenue history · segment & region breakdown
MRM · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsMEDIROM Healthcare Technologies Inc. trailing twelve-month (TTM) revenue is $12.06B, a decrease of 99.95% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2018 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.00B | -$8.30B | -99.95% |
| 2024-12-31 | $8.30B | +$1.47B | +21.55% |
| 2023-12-31 | $6.83B | -$0.13B | -1.81% |
| 2022-12-31 | $6.95B | +$1.54B | +28.54% |
| 2021-12-31 | $5.41B | +$2.07B | +61.89% |
| 2020-12-31 | $3.34B | -$0.57B | -14.50% |
| 2019-12-31 | $3.91B | +$0.48B | +13.84% |
| 2018-12-31 | $3.43B | — | — |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income MEDIROM Healthcare Technologies Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
MEDIROM Healthcare Technologies Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in JPY.
Data sourced from MEDIROM Healthcare Technologies Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
MRM revenue · 4 questionsMRM's trailing twelve-month (TTM) revenue is $12.06B. That is a decrease of 99.95% year-over-year from $0.00B in FY2025.
▸ Source: FMP · MEDIROM Healthcare Technologies Inc. SEC filings · GAAP · MEDIROM Healthcare Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026